Company Overview - TGE Value Creative Solutions Corp is a special purpose acquisition company (SPAC) sponsored by The Generation Essentials Group, formed to engage in business combinations with various entities [3] - The company is registered in the Cayman Islands and aims to focus on high potential businesses in sectors such as media, digital media, entertainment, high fashion, lifestyle, culture, and gaming [3] Initial Public Offering (IPO) Details - The company has successfully priced its initial public offering at $10.00 per unit, consisting of 15,000,000 units [1] - The units will be listed on the New York Stock Exchange under the ticker symbol "BEBE U" and will begin trading on December 19, 2025 [1] - Each unit includes one Class A ordinary share and one-half of a redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at $11.50 per share [1] Underwriting and Additional Options - Cohen & Company Capital Markets acted as the sole underwriter and book-running manager for the offering [4] - The underwriter has been granted a 45-day option to purchase up to an additional 2,250,000 units at the IPO price to cover overallotments [4]

Core Viewpoint - Medline Inc. has successfully completed its upsized initial public offering (IPO) of 248,439,654 shares of Class A common stock at a price of $29.00 per share, including the underwriters' option to purchase an additional 32,405,172 shares [1] Group 1: IPO Details - The proceeds from the issuance of 179,000,000 shares will be used to repay outstanding indebtedness under senior secured term loan facilities, with the remainder allocated for general corporate purposes and offering expenses [2] - Medline plans to use proceeds from the issuance of 37,034,482 shares and the additional shares purchased by underwriters to buy or redeem an equivalent number of outstanding equity interests from certain pre-IPO owners [2] - The Class A common stock of Medline is listed on the Nasdaq Global Select Market under the symbol "MDLN" [2] Group 2: Underwriters and Managers - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan acted as global coordinators and lead bookrunning managers for the offering [2] - A wide range of firms, including Barclays, Citigroup, and Deutsche Bank Securities, served as bookrunning managers, while numerous others acted as co-managers for the offering [2] Group 3: Company Overview - Medline is the largest provider of medical-surgical products and supply chain solutions, serving all points of care [5] - The company has a broad product portfolio, resilient supply chain, and leading clinical solutions aimed at improving clinical, financial, and operational outcomes for healthcare providers [5] - Headquartered in Northfield, Illinois, Medline employs over 43,000 people globally and operates in more than 100 countries [5]

BOCA RATON, Fla.--(BUSINESS WIRE)--Iron Horse Acquisition II Corp. Announces Closing of $230,000,000 Initial Public Offering. ...

Company Overview - Launchpad Cadenza Acquisition Corp I is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The primary focus of the company will be on technology and software infrastructure companies operating within the blockchain, financial technology, and digital assets ecosystems [2] Initial Public Offering (IPO) Details - The company announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit, with trading expected to begin on December 18, 2025, under the ticker symbol "LPCVU" [1] - Each unit consists of one Class A ordinary share and one-third of one redeemable warrant, with the whole warrant allowing the holder to purchase one Class A ordinary share at a price of $11.50 per share [1] - An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering, which is expected to close on December 19, 2025 [1] - The underwriters have been granted a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments [1] Management Team - The management team is led by Max Shapiro (CEO), Jurgen van de Vyver (CFO), and Kumar Dandapani (Chairman of the Board), with additional board members Sean O'Malley and Jonathan Bier [3]

Core Points - Vine Hill Capital Investment Corp. II has announced the pricing of its upsized initial public offering (IPO) of 20,000,000 units at a price of $10.00 per unit, with trading expected to begin on Nasdaq under the ticker symbol "VHCPU" on December 18, 2025 [1] - Each unit consists of one Class A ordinary share and one-third of a redeemable warrant, with each whole warrant allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1] - The offering is expected to close on December 19, 2025, subject to customary closing conditions [1] Company Overview - The Company was formed to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, focusing on industries that complement its management team's background [2] Underwriting and Legal Counsel - Stifel, Nicolaus & Company, Incorporated is acting as the sole book-running manager for the offering, with a 45-day option granted to underwriters to purchase up to 3,000,000 additional units to cover over-allotments [3] - Paul Hastings LLP is serving as legal counsel to the Company, while Greenberg Traurig, LLP is serving as legal counsel to the underwriters [3] Prospectus Information - The public offering is being made only by means of a prospectus, which can be obtained from Stifel, Nicolaus & Company, Incorporated [4] Regulatory Approval - A registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (SEC) on December 17, 2025 [5]

Medline shares surged more than 40% in their hotly anticipated New York debut on Wednesday, valuing the medical supply giant at $54 billion in the largest US initial public offering since Rivian’s 2021 listing, capping a strong year for new listings and fueling optimism for 2026.Shares of the company opened at $35, compared with its IPO price of $29 per share. The stock closed at $41.The medical supplies maker and distributor — acquired for $34 billion in 2021 by Blackstone, Carlyle and Hellman & Friedman i ...

Key Takeaways Citigroup projects mid-20% y/y growth in 4Q25 investment banking fees, driven by deal-making momentum. Management cited mega deals and investment-grade activity as key contributors to IB fee growth. Markets revenues are expected to fall y/y in the low to mid-single digits despite investment banking strength.At the 2025 Goldman Sachs U.S. Financial Services Conference, Citigroup, Inc.’s (C) chief financial officer Mark Mason stated that the company’s investment banking (IB) fees are expected to ...

Medline raised about $6.26 billion in an upsized initial public offering, pricing its shares near the top of a marketed range, according to a source https://t.co/KxBxctef4x ...

Key Takeaways Goldman reported $3.37B in M&A advisory fees in the first nine months of 2025, reflecting higher deal volumes.GS equity and debt underwriting fees rose 7% and 11% in YTD 2025, adding support to overall IB revenue growth.GS management expects improved financing conditions to accelerate delayed M&A and capital-raisingThe Goldman Sachs Group’s (GS) chief financial officer, Denis Coleman, affirmed its strong confidence in global mergers and acquisitions (M&A) at the firm’s 2025 Global Conference h ...

Hong Kong red-hot market for initial public offerings is set to close the year with its busiest month for listings in at least four years as companies rush to list their shares https://t.co/ERwnRgkzoi ...